| Application no. and date | 17206868.6 (espacenet) (Federated) (European Patent Register), 20091106 | | Patent/reg. no. and date | DK/EP 3330293, 20190724 | | Publication date | 20180606 | | Priority no. and date | US 112323 P, 20081107, US 183291 P, 20090602, US 221269 P, 20090629 | | EP pub. no. and date |
EP 3330293 20180606 | | Effective date | | | Applicant/owner | Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | 1518610 | | Inventor | ZUGMAIER, Gerhard, c/o Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 Munich, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/46 (2006.01) | | Title | Behandling af pædiatrisk akut lymfoblastær leukæmi med bispecifikke antistoffer mod CD3xCD19 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
